Erratum: Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands (The EMBO Journal (2009) 28 (3579-3590) DOI: 10.1038/emboj.2009.286;Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands

EMBO Journal

Volumn 28, Issue 22, 2009, Pages 3579-3590

  Joyce, Sebastian ^a   Florence, William C ^a   Xia, Chengfeng ^b   Gordy, Laura E ^a   Chen, Wenlan ^b   Zhang, Yalong ^b   Scott Browne, James ^c   Kinjo, Yuki ^d   Yu, Karl O A ^e   Keshipeddy, Santosh ^f   Pellicci, Daniel G ^g   Patel, Onisha ^h   Kjer Nielsen, Lars ^g   McCluskey, James ^h   Godfrey, Dale I ^g   Rossjohn, Jamie ^h   Richardson, Stewart K ^f   Porcelli, Steven A ^e   Howell, Amy R ^f   Hayakawa, Kyoko ⁱ   Gapin, Laurent ^c   Zajonc, Dirk M ^d   Wang, Peng George ^b   more..

^a VANDERBILT UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CONNECTICUT   (United States)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h MONASH UNIVERSITY   (Australia)

ⁱ FOX CHASE CANCER CENTER   (United States)

Author keywords

Antigen recognition; Glycolipid antigens; NKT cells; Recognition logic; Semi invariant T cell receptor

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CERAMIDE DERIVATIVE; EPITOPE; NATURAL KILLER T CELL RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGEN STRUCTURE; ARTICLE; BETA CHAIN; BINDING SITE; CONTROLLED STUDY; MOLECULAR DOCKING; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ADAPTATION, BIOLOGICAL; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELLS, CULTURED; GALACTOSYLCERAMIDES; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STRUCTURE-ACTIVITY RELATIONSHIP; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 70450224082     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2009.348     Document Type: Erratum

References (37)

1. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, Koh R, Besra GS, Bharadwaj M, Godfrey DI, McCluskey J, Rossjohn J (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448: 44-49
2. Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M (1998) Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates Valpha14+ NK T lymphocytes. J Immunol 161: 3271-3281
3. Cantu III C, Benlagha K, Savage PB, Bendelac A, Teyton L (2003) The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. J Immunol 170: 4673-4682
4. Capone M, Cantarella D, Schumann J, Naidenko OV, Garavaglia C, Beermann F, Kronenberg M, Dellabona P, MacDonald HR, Casorati G (2003) Human invariant Valpha24-JalphaQ TCR supports the development of CD1d-dependent NK1.1+ and NK1.1 - T cells in transgenic mice. J Immunol 170: 2390-2398
5. Chen W, Xia C, Wang J, Thapa P, Li Y, Nadas J, Zhang W, Zhou D, Wang PG (2007) Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues. J Org Chem 72: 9914-9923
6. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A (1994) An invariant V alpha 24-JalphaQ/Vbeta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 180: 1171-1176
7. Fischer K, Scotet E, Niemeyer M, Koebernick H, Zerrahn J, Maillet S, Hurwitz R, Kursar M, Bonneville M, Kaufmann SH, Schaible UE (2004) Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 101: 10685-10690
8. Gadola SD, Koch M, Marles-Wright J, Lissin NM, Shepherd D, Matulis G, Harlos K, Villiger PM, Stuart DI, Jakobsen BK, Cerundolo V, Jones EY (2006) Structure and binding kinetics of three different human CD1d-alpha- galactosylceramide-specific T cell receptors. J Exp Med 203: 699-710
9. Giabbai B, Sidobre S, Crispin MD, Sanchez-Ruiz Y, Bachi A, Kronenberg M, Wilson IA, Degano M (2005) Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation. J Immunol 175: 977-984
10. Gui M, Li J, Wen LJ, Hardy RR, Hayakawa K (2001) TCR beta chain influences but does not solely control autoreactivity of Va14Ja281T cells. J Immunol 167: 6239-6246
11. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221
12. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629
13. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, Tsuji M, Sellati TJ, Wong CH, Kronenberg M (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986
14. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525
15. Kjer-Nielsen L, Borg NA, Pellicci DG, Beddoe T, Kostenko L, Clements CS, Williamson NA, Smyth MJ, Besra GS, Reid HH, Bharadwaj M, Godfrey DI, Rossjohn J, McCluskey J (2006) A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J Exp Med 203: 661-673
16. Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, Ritter G, Fersht AR, Besra GS, Schmidt RR, Jones EY, Cerundolo V (2005) The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol 6: 819-826
17. Koseki H, Imai K, Nakayama F, Sado T, Moriwaki K, Taniguchi M (1990) Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice. Proc Natl Acad Sci USA 87: 5248-5252
18. Lantz O, Bendelac A (1994) An invariant Tcell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180: 1097-1106
19. Mallevaey T, Scott-Browne JP, Matsuda JL, Young MH, Pellicci DG, Patel O, Thakur M, Kjer-Nielsen L, Richardson SK, Cerundolo V, Howell AR, McCluskey J, Godfrey DI, Rossjohn J, Marrack P, Gapin L (2009) Tcell receptor CDR2b and CDR3b loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31: 60-71
20. Mattner J, Debord KL, Ismail N, Goff RD, Cantu III C, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529
21. Ortaldo JR, Young HA, Winkler-Pickett RT, Bere Jr EW, Murphy WJ, Wiltrout RH (2004) Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol 172: 943-953
22. Parekh VV, Singh AK, Wilson MT, Olivares-Villagomez D, Bezbradica JS, Inazawa H, Ehara H, Sakai T, Serizawa I, Wu L, Wang CR, Joyce S, Van Kaer L (2004) Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha-and beta-anomeric glycolipids. J Immunol 173: 3693-3706
23. Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, Kyparissoudis K, Brooks AG, Reid HH, Gras S, Lucet I, Koh R, Smyth MJ, Mallevaey T, Matsuda JL, Gapin L, McCluskey J, Godfrey DI, Rossjohn J (2009) Differential recognition of CD1d-a-galactosyl ceramide by the Vb8.2 and Vb7 semi-invariant NKT T-cell receptors. Immunity 31: 47-59
24. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178: 1-16
25. Rauch J, Gumperz J, Robinson C, Skold M, Roy C, Young DC, Lafleur M, Moody DB, Brenner MB, Costello CE, Behar SM (2003) Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J Biol Chem 278: 47508-47515
26. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419-466
27. Scott-Browne JP, Matsuda JL, Mallevaey T, White J, Borg NA, McCluskey J, Rossjohn J, Kappler J, Marrack P, Gapin L (2007) Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 8: 1105-1113
28. Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR (2005) Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 35: 1692-1701
29. Tynan FE, Reid HH, Kjer-Nielsen L, Miles JJ, Wilce MC, Kostenko L, Borg NA, Williamson NA, Beddoe T, Purcell AW, Burrows SR, McCluskey J, Rossjohn J (2007) A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 8: 268-276
30. Van Kaer L (2005) Alpha-galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 5: 31-42
31. Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 198: 173-181 (Pubitemid 36870197)
32. Wun KS, Borg NA, Kjer-Nielsen L, Beddoe T, Koh R, Richardson SK, Thakur M, Howell AR, Scott-Browne JP, Gapin L, Godfrey DI, McCluskey J, Rossjohn J (2008) A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 205: 939-949
33. Xia C, Zhang W, Zhang Y, Chen W, Nadas J, Woodward R, Wang B, Wang X, Kronenberg M, Wang PG (2009) Roles of 3' and 4' hydroxyls in a-galactosylceramide stimulation of invariant natural killer T cells. Chem Med Chem (doi:10.1002/cmdc.200900350)
34. Zajonc DM, Ainge GD, Painter GF, Severn WB, Wilson IA (2006) Structural characterization of mycobacterial phosphatidy-linositol mannoside binding to mouse CD1d. J Immunol 177: 4577-4583
35. Zajonc DM, Cantu III C, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA, Teyton L (2005) Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 6: 810-818
36. Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L (2008) Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J Mol Biol 377: 1104-1116
37. Zhou D, Mattner J, Cantu III C, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789